StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research note issued to investors on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Up 42.1 % Shares of SRNE opened at $0.15 on Friday. The company has a debt-to-equity ratio of 0.14, a […]
StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research note issued to investors on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Up 42.1 % Shares of NASDAQ SRNE opened at $0.15 on Friday. The business has a fifty day simple moving […]
StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report issued on Wednesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance NASDAQ:SRNE opened at $0.04 on Wednesday. The business has a fifty day simple moving average of $0.08 and a two-hundred day simple […]
StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research report report published on Wednesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance NASDAQ:SRNE opened at $0.04 on Wednesday. Sorrento Therapeutics has a 52 week low of $0.16 and a 52 week […]
StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research report sent to investors on Tuesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Trading Up 15.7 % Shares of Sorrento Therapeutics stock opened at $0.05 on Tuesday. The business’s fifty day moving average price […]